单针远端回流技术实现零导管并改善功能不良动静脉瘘患者结局
结果显示转诊患者基线代谢更差且CVC携带率更高;
要点
- 转诊患者基线血钾、NT-proBNP及CVC携带率显著高于中心内患者。
- SNDR零导管方案将临时CVC使用率从24.2%降至0%。
核心结论
- 基于SNDR的零导管策略可消除临时导管依赖、稳定代谢并改善通路结局。
研究设计与样本
- 单中心回顾性队列研究,纳入所有因AVF功能障碍接受PTA的维持性血透患者。
- 研究分两阶段:阶段1(2023年2月至2024年3月,常规护理)和阶段2(2024年4月至2026年2月,零导管SNDR方案)。
主要发现
- 阶段2(n=237)较阶段1(n=215)临时CVC使用从24.2%降至0%(p<.001)。
- PTA等待时间从4.2±2.5天缩短至1.9±1.3天(p<.001)。
- 首次PTA后透析充分性spKt/V从1.21±0.18改善至1.48±0.15(p<.001)。
临床怎么用
- 对功能不良AVF的PTA围术期可采用SNDR零导管策略以减少临时CVC依赖。
- 转诊患者围术期风险更高,应优先纳入零导管管理路径。
局限性
- 单中心回顾性设计,阶段间比较可能存在时间偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The peri-procedural window surrounding percutaneous transluminal angioplasty (PTA) for dysfunctional arteriovenous fistula (AVF) is a high risk phase often complicated by metabolic instability and temporary central venous catheter (CVC) dependence. This study characterised this window and evaluated a zero catheter multidisciplinary strategy centred on the single needle distal return (SNDR) technique. METHODS: This single centre, retrospective cohort study included all maintenance haemodialysis patients who underwent PTA for AVF dysfunction. The study had two phases: phase 1 (conventional care, February 2023 - March 2024) and phase 2 (zero catheter SNDR protocol, April 2024 - February 2026). Patients were categorised by source (in centre vs. referred). Clinical characteristics at presentation were compared between sources. Peri-procedural outcomes were compared between phases. The primary outcome was temporary CVC use. RESULTS: Four hundred and fifty-two patients (700 procedures) were included. Referred patients (n = 186) exhibited significantly worse profiles at presentation than in centre patients (n = 266): higher potassium (6.2 ± 1.9 vs. 5.1 ± 0.8 mmol/L), elevated NT-proBNP (1 850 vs. 852 pg/mL), and higher prevalence of pre-existing CVCs (31.7% vs. 0.8%, all p < .001). After SNDR protocol implementation, phase 2 (n = 237) demonstrated more dramatic improvements than phase 1 (n = 215): CVC use decreased from 24.2% to 0% (p < .001), time to PTA shortened from 4.2 ± 2.5 to 1.9 ± 1.3 days (p < .001), and first post-PTA dialysis adequacy (spKt/V) improved from 1.21 ± 0.18 to 1.48 ± 0.15 (p < .001). All 32 referred patients arriving with CVCs in phase 2 had them removed within 24 hours. Ninety day re-intervention free survival improved significantly in phase 2 (log rank p < .010). CONCLUSION: Referred patients bear a disproportionately higher burden of peri-procedural complications. Implementation of a zero catheter SNDR based strategy effectively eliminated temporary catheter dependence, stabilised metabolic profiles, and improved access outcomes, offering a reproducible framework for optimising peri-PTA care.
引用
- Wu S, Zhao D, Xu L, et al. Single Needle Distal Return Technique Achieves Zero Catheter and Improves Outcomes in Patients with Dysfunctional Arteriovenous Fistulas. Eur J Vasc Endovasc Surg. 2026. PMID: 42401280. doi:10.1016/j.ejvs.2026.06.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。